Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adamantane SCHEMBL27571882 | 0.95 | CYP2C9 (0.44) | CYP2C9TSHREPHX2HSD17B10L3MBTL1 | |
| Adamantane SCHEMBL27518603 | 0.95 | CYP2C9 (0.44) | CYP2C9TSHREPHX2HSD17B10L3MBTL1 | |
| Adamantane SCHEMBL27604496 | 0.82 | CYP2C9 (0.50) | CYP2C9TSHREPHX2HSD11B1GRIN2D | |
| Adamantane SCHEMBL1527414 | 0.82 | CYP2C9 (0.46) | CYP2C9TSHREPHX2HSD11B1GRIN2D | |
| Adamantane SCHEMBL29707714 | 0.82 | CYP2C9 (0.46) | CYP2C9TSHREPHX2HSD11B1GRIN2D | |
| Adamantane SCHEMBL12761 | 0.82 | CYP2C9 (0.46) | CYP2C9TSHREPHX2HSD11B1GRIN2D | |
| Adamantane SCHEMBL9016497 | 0.82 | CYP2C9 (0.46) | CYP2C9TSHREPHX2HSD11B1GRIN2D | |
| Methyl Alcohol SCHEMBL949195 | 0.80 | — | — | |
| Methyl Alcohol SCHEMBL3184397 | 0.80 | CYP2C9 (0.33) | CYP2C9HSD17B10L3MBTL1 | |
| Methyl Alcohol SCHEMBL27678983 | 0.80 | CYP2C9 (0.33) | CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120005952-A | High-purity synthesis process of amantadine hydrochloride by utilizing specific enzymatic reaction | 天津民祥生物医药股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-117070172-B | High-refractive-index high-toughness yellowing-resistant mini LED (light-emitting diode) epoxy packaging adhesive and preparation method thereof | 信泰永合(烟台)新材料有限公司 | 2024-01-02 | — | — | CN | claimed |
| CN-117070172-A | High-folding high-toughness yellowing-resistant mini LED (light-emitting diode) epoxy packaging adhesive and preparation method thereof | 信泰永合(烟台)新材料有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116396668-B | Epoxy resin sports floor material and preparation method thereof | 山东体育学院 | 2023-11-14 | — | — | CN | claimed |
| CN-116396668-A | Epoxy resin sports floor material and preparation method thereof | 山东体育学院 | 2023-07-07 | — | — | CN | claimed |
| CN-116355670-A | Preparation method of low-sulfur high-energy-density ship fuel | 南方科技大学 | 2023-06-30 | — | — | CN | claimed |
| CN-105294428-B | 2-adamantanecarboxylic acid and 1-adamantane methanol separation and purification method | 浙江师范大学 | 2017-05-10 | — | — | CN | claimed |
| CN-104725194-B | A kind of preparation method of adamantane alcohol compound | 泸州大洲化工有限公司 | 2016-08-17 | — | — | CN | claimed |
| US-8481016-B2 | Method for inhibition of potential-dependent cation channel | KAO CORPORATION (JP) | 2013-07-09 | — | — | US | claimed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | claimed |
| US-20050142487-A1 | Polymerizable adamantane derivative, production process thereof and polymeric compound | DAICEL CHEMICAL INDUSTRIES, LTD. | 2005-06-30 | — | — | US | claimed |
| US-6797745-B1 | Hot melt inks containing styrene or terpene polymers | XEROX CORPORATION | 2004-09-28 | — | — | US | claimed |
| JP-57079187-A | — | — | None | — | — | JP | disclosed |
| WO-2026100281-A1 | RADIATION-SENSITIVE COMPOSITION, PATTERN FORMATION METHOD, RADIATION-SENSITIVE ACID GENERATOR, AND COMPOUND | JSR株式会社 | 2026-05-15 | — | — | WO | disclosed |
| CN-122051387-A | High-safety electrolyte additive for lithium ion battery | 贵州航盛锂能科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121873033-A | Adamantane carbonate derived photoacid generator and preparation method thereof | 威迈芯材(合肥)半导体有限公司 | 2026-04-17 | — | — | CN | disclosed |
| US-4727072-A | HYPOTENSIVE AGENTS | MCNEILAB, INC. (US) | 1988-02-23 | — | — | US | disclosed |
| EP-0237191-A1 | 3-alkoxy-2-aminopropylamines useful as cardiovascular agents | McNeilab, Inc. (US) | 1987-09-16 | — | — | EP | disclosed |
| EP-0223421-A2 | Chlorination of carbohydrates and other alcohols | McNeilab, Inc. (US) | 1987-05-27 | — | — | EP | disclosed |
| JP-S5779187-A | MANUFACTURE OF PERFLUORO(ALKYL-SUBSTITUTED ADAMANTANE) | AGENCY OF IND SCIENCE & TECHNOL | 1982-05-18 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | CYP2C9 795/4885TSHR 1275/4885EPHX2 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.